Related Experiment Video
Updated: Jul 9, 2026

Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
Role of short-chain hydroxyacyl CoA dehydrogenases in SCHAD deficiency
Charlotta Filling1, Brigitte Keller, Daniel Hirschberg
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Insights
Short-chain hydroxyacyl CoA dehydrogenase deficiency, a severe pediatric disorder, is primarily linked to HADH 1 enzyme activity. Protein interactions, not HADH mutations, likely cause the disease, potentially involving glutamate dehydrogenase.
Area of Science:
- Biochemistry
- Metabolic disorders
- Pediatric medicine
Background:
- Short-chain hydroxyacyl CoA dehydrogenase deficiency (SCHAD) is a poorly understood pediatric disorder affecting mitochondrial fatty acid beta-oxidation.
- Two key enzymes, HADH 1 and HADH 2, are involved in metabolizing short-chain hydroxyacyl-CoAs.
Purpose of the Study:
- To investigate the roles of HADH 1 and HADH 2 in SCHAD.
- To identify the underlying molecular mechanisms of the disorder.
Main Methods:
- Analysis of tissue biopsies from affected families.
- Comparison of kinetic parameters for HADH 1 and HADH 2.
- Protein interaction studies using recombinant enzymes and mitochondrial extracts.
Main Results:
- Kinetic analysis indicates HADH 1 is the primary enzyme in short-chain hydroxyacyl-CoA beta-oxidation.
- No mutations were found in the HADH 2 gene of patients.
- Two proteins, including glutamate dehydrogenase, were found to interact with HADH 1.
Conclusions:
- Protein interactions, rather than HADH mutations, are implicated in the disease phenotype.
- The interaction between HADH 1 and glutamate dehydrogenase suggests a link between fatty acid metabolism and hyperinsulinism/hyperammonia syndrome.
Abstract:
Short-chain hydroxyacyl CoA dehydrogenase deficiency is an ill-defined, severe pediatric disorder of mitochondrial fatty acid beta-oxidation of short-chain hydroxyacyl CoAs. To understand the relative contributions of the two known short-chain hydroxyacyl CoA dehydrogenases (HADH) tissue biopsies of six distinct family individuals were analyzed and kinetic parameters were compared. Steady-state kinetic constants for HADH 1 and HADH 2 suggest that type 1 is the major enzyme involved in mitochondrial beta-oxidation of short-chain hydroxyacyl-CoAs. Two patients are heterozygous carriers of a HADH 1 polymorphism, whereas no mutation is detected in the HADH 2 gene of all patients. The data suggest that protein interactions rather than HADH mutations are responsible for the disease phenotype. Pull-down experiments of recombinant HADH 1 and 2 with human mitochondrial extracts reveal two proteins interacting with HADH 1, one of which was identified as glutamate dehydrogenase. This association provides a possible link between fatty acid metabolism and the hyperinsulinism/hyperammonia syndrome.
More Related Videos
07:34Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Published on: November 23, 2011
Related Concept Videos
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Role of Reduced Coenzymes NADH and FADH₂
Lipid Catabolism
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Inborn Errors of Metabolism